We previously showed that parvalbumin D2 mutant animals exhibit molecular, cellular, physiological, and behavioral impairments highly reminiscent of symptoms observed in schizophrenia patients and a parallel developmental onset [16]. The gene discussed is PVALB; the disease is schizophrenia.